58 related articles for article (PubMed ID: 27385330)
1. Secreted Frizzled-Related Protein 4 (SFRP4): A Novel Biomarker of β-Cell Dysfunction and Insulin Resistance in Individuals With Prediabetes and Type 2 Diabetes.
Anand K; Vidyasagar S; Lasrado I; Pandey GK; Amutha A; Ranjani H; Mohan Anjana R; Mohan V; Gokulakrishnan K
Diabetes Care; 2016 Sep; 39(9):e147-8. PubMed ID: 27385330
[No Abstract] [Full Text] [Related]
2. Secreted frizzled-related protein 4 (SFRP4) and fractalkine (CX3CL1) - Potential new biomarkers for β-cell dysfunction and diabetes.
Bergmann K; Sypniewska G
Clin Biochem; 2014 May; 47(7-8):529-32. PubMed ID: 24675103
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
[TBL] [Abstract][Full Text] [Related]
5. Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease.
Hoffmann MM; Werner C; Böhm M; Laufs U; Winkler K
Cardiovasc Diabetol; 2014 Nov; 13():155. PubMed ID: 25408147
[TBL] [Abstract][Full Text] [Related]
6. Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus.
Brix JM; Krzizek EC; Hoebaus C; Ludvik B; Schernthaner G; Schernthaner GH
Horm Metab Res; 2016 May; 48(5):345-8. PubMed ID: 26882051
[TBL] [Abstract][Full Text] [Related]
7. Loss of SFRP4 Alters Body Size, Food Intake, and Energy Expenditure in Diet-Induced Obese Male Mice.
Mastaitis J; Eckersdorff M; Min S; Xin Y; Cavino K; Aglione J; Okamoto H; Na E; Stitt T; Dominguez MG; Schmahl JP; Lin C; Gale NW; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gromada J
Endocrinology; 2015 Dec; 156(12):4502-10. PubMed ID: 26406932
[TBL] [Abstract][Full Text] [Related]
8. Identification of Ascorbic Acid and Gallic Acid as Novel Inhibitors of Secreted Frizzled-Related Protein for the Treatment of Obesity-Induced Type 2 Diabetes.
Bukhari SA; Yasmin A; Rasul A; Zahoor MA; Mustafa G; Al Farraj DA; Darwish NM; Aleya L; Rehman A
Dose Response; 2022; 20(1):15593258211069707. PubMed ID: 35145353
[TBL] [Abstract][Full Text] [Related]
9. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract][Full Text] [Related]
11. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
13. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
14. Placental expression of secreted frizzled related protein-4 in the rat and the impact of glucocorticoid-induced fetal and placental growth restriction.
Hewitt DP; Mark PJ; Dharmarajan AM; Waddell BJ
Biol Reprod; 2006 Jul; 75(1):75-81. PubMed ID: 16540541
[TBL] [Abstract][Full Text] [Related]
15. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
Surendran K; Schiavi S; Hruska KA
J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
[TBL] [Abstract][Full Text] [Related]
16. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
[TBL] [Abstract][Full Text] [Related]
18. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
19. Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a.
Perumal V; Krishnan K; Gratton E; Dharmarajan AM; Fox SA
Int J Biochem Cell Biol; 2015 Jul; 64():91-6. PubMed ID: 25805505
[TBL] [Abstract][Full Text] [Related]
20. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]